AnaptysBio Inc. (NASDAQ: ANAB) announced its board of directors approved the spin-off of First Tracks Biotherapeutics Inc., with the new ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE